ÎÛÎÛ²ÝÝ®ÊÓƵ

New Therapeutic Trial Designs in Personalized Medicine: Molecular Oncology

Ìý

The Molecular Oncology research team includes internationally recognized researchers with expertise in regulation of oncogene expression, signal transduction, evaluation of normal and malignant development in animal models, structural biology and bioinformatics. Their focus is on the molecular mechanisms underlying oncogenic development.

Theme leaders:

Dr. Wilson H. Miller Jr, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Sarit Assouline, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Members:

Dr. Mark Basik, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Volker Blank, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Sonia del Rincon, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Antonis Koromilas, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Alexandre Orthwein, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Stéphane Richard, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Josie Ursini-Siegel, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Dr. Alan Spatz, Lady Davis Institute for Medical Research, ÎÛÎÛ²ÝÝ®ÊÓƵ University

Back to top